Bank Ganesha Tbk vs Merck Tbk. — how do they compare? Bank Ganesha Tbk trades at Rp110 (market cap 2.59T, 543.6K 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Bank Ganesha Tbk is the larger of the two by market cap, and Bank Ganesha Tbk is more actively traded (543.6K versus 22.8K). Which is the better fit depends on your goals.
| BGTG | MERK | |
|---|---|---|
Market Cap | 2.59T | 1.68T |
Volume | 543.6K | 22.8K |
Lot | 5.44K | 228 |
Turnover | 59.52M | 82.9M |
Average Price | 109.49 | 3,636.14 |
Value | 59.52M | 82.9M |
Indicative Equilibrium Price | 110 | 3,520 |
Indicative Equilibrium Volume | 87 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
P.T. Bank Ganesha Tbk (”the Bank”) was established based on Deed No. 47 dated May 15, 1990 of notary Esther Daniar Iskandar S.H. The Bank started commercial operations on April 30, 1992 when it obtained its business license based on the Decision Letter No. 393/KMK-013/1992 dated April 14, 1992 from the Minister of Finance of the Republic of Indonesia. In accordance with Bank Indonesia’sDecision Letter No. 26/66/KEP/DIR dated September 12, 1995, the Bank is authorized to be a foreign exchange bank.
Read more on BGTG →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →